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An Alternatively Spliced C. elegans ced-4 RNA
Encodes a Novel Cell Death Inhibitor
Shai Shaham* and H. Robert Horvitz ALM neurons by overexpression of ced-4 is greatly re-
duced in ced-3 mutants, whereas killing of theseHoward Hughes Medical Institute
neurons by overexpression of ced-3 is unaffected byDepartment of Biology
mutations in ced-4, suggesting that ced-3 might actMassachusetts Institute of Technology
downstream of ced-4 (Shaham and Horvitz, 1996).Cambridge, Massachusetts 02139
ced-3, ced-4, and ced-9 all act cell autonomously (Yuan
and Horvitz, 1990; Shaham and Horvitz, 1996).
The CED-9 protein is similar in sequence to the mam-
Summary malian cell death inhibitor protein BCL-2, which like
CED-9 functions to prevent programmed cell death
The C. elegans gene ced-4 is essential for pro- (Vaux et al., 1988; Nunez et al., 1990; Garcia et al., 1992;
grammed cell death. We report that ced-4 encodes Sentman et al., 1992). The CED-3 protein is similar in
two transcripts and that whereas the major transcript sequence to members of the interleukin-1b-converting
can cause programmed cell death, the minor tran- enzyme (ICE) family of cysteine proteases, which can
script can act oppositely and prevent programmed induce apoptotic cell deaths (Miura et al., 1993; Yuan
cell death, thus defining a novel class of cell death et al., 1993; Fernandes-Alnemri et al., 1994, 1995; Kumar
inhibitors. That ced-4 has both cell-killing and cell- et al., 1994; Wang et al., 1994; Faucheu et al., 1995;
protective functions is consistent with previous ge- Munday et al., 1995). A number of reports indicate that
netic studies. Our results suggest that the dual protec- cell death induced by mammalian CED-3-like proteins
tive and killer functions of the C. elegans bcl-2-like can be inhibited by overexpression of BCL-2 (Miura et
gene ced-9 are mediated by inhibition of the killer and al., 1993; Kumar et al., 1994; Wang et al., 1994), sug-
protective ced-4 functions, respectively. We propose gesting that BCL-2 might prevent the actions of CED-
that a balance between opposing ced-4 functions in- 3-like proteases to inhibit programmed cell death just
fluences the decision of a cell to live or to die by as CED-9 protein prevents the action of CED-3 in worms.
programmed cell death and that both ced-9 and ced-4 No mammalian protein structurally similar to CED-4 has
protective functions are required to prevent pro- been described. Nevertheless, our recent finding that
grammed cell death. ced-4 might mediate protection by ced-9 against ced-
3-induced death (Shaham and Horvitz, 1996) suggests
that in mammals a CED-4-like protein might mediateIntroduction
protection by BCL-2-like proteins against death induced
by CED-3-like proteases. If so, studies of how ced-4Programmed cell death is a major aspect of metazoan
acts could provide insights concerning universal mecha-development (e.g., Glu¨cksmann, 1950; Duvall and Wyllie,
nisms that regulate programmed cell death.1986; Ellis et al., 1991; Oppenheim, 1991). During the
In this report we show that the ced-4 gene encodesdevelopment of the nematode Caenorhabditis elegans,
two alternatively spliced mRNAs, calledced-4L and ced-131 of the 1090 cells generated undergo programmed
4S, that encode opposing functions. Whereas ced-4S,cell death (Sulston and Horvitz, 1977; Sulston et al.,
the previously identified ced-4 transcript (Yuan and Hor-1983). Mutations affecting the process of programmed
vitz, 1992), can induce programmed cell death, ced-cell death in C. elegans have been isolated and have
4L can protect cells from programmed cell death, thusdefined 14 genes (reviewed by Horvitz et al., 1994). Loss-
defining a novel class of cell death inhibitors. Both tran-of-function (lf) mutations in the genes ced-3 and ced-4,
scripts are likely to be conserved between C. elegansa gain-of-function mutation in the gene ced-9,or overex-
and the related nematodes C. briggsae and C. vulgaris,pression of the wild-type ced-9 gene can prevent pro-
since the ced-4L alternative exon is conserved amonggrammed cell death (Ellis and Horvitz, 1986; Hengartner
all three species. We report that ced-4 encodes twoet al., 1992; Hengartner and Horvitz, 1994b). By contrast,
opposing genetic cell death functions and suggest thatced-9(lf) mutations or overexpression of the wild-type
these two functions correspond to the two distinct ced-4ced-3 or ced-4 genes can cause cells that normally
transcripts, indicating that alternative splicing is nor-survive instead to undergo programmed cell death
mally used in vivo to regulate programmed cell death.(Hengartner et al., 1992; Shaham and Horvitz, 1996).
Finally, our results suggest that the activities of bothThese results indicate that ced-3 and ced-4 can cause
ced-4L and ced-4S are inhibited by the activity of theand ced-9 can prevent programmed cell death. Loss-
ced-9 gene. This finding can account for the ability ofof-function mutations in either ced-3 or ced-4 can pre-
ced-9 both to promote and to prevent programmed cellvent both ectopic and normal cell deaths that occur in
death (Hengartner and Horvitz, 1994a) and suggests thatced-9(lf) animals, suggesting that the function of ced-9
other CED-9-like proteins might also be able both tois to prevent ced-3, ced-4, or both from acting (Hengart-
promote and to prevent cell death by inhibiting CED-4L-ner et al., 1992). In addition, the killing of the C. elegans
like and CED-4S-like proteins, respectively. We propose
that ced-9 and ced-4L are both required to prevent pro-
grammed cell death and that the balance between ced-*Present address: Department of Biochemistry and Biophysics,
4L and ced-4S determines whether a cell will live or dieUniversity of California, San Francisco, San Francisco, California
94143-0448. by programmed cell death.
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Results lines containing a ced-4L cDNA fused to two different
heat-shock promoters (A. Fire and P. Candido, personal
communication). Again, no ectopic cell deaths were ob-A Conserved ced-4 Sequence Is Used as
an Alternative Exon served; instead, extra cells accumulated in the anterior
pharynx of transgenic embryos subjected to a heatTo define functionally important regions of ced-4, we
cloned and determined the sequences of ced-4 homo- shock (Table 1), as in animals containing death-pre-
venting mutations. This result suggested that pro-logs from the nematodes C. briggsae and C. vulgaris. By
comparing complete C. briggsae and partial C. vulgaris grammed cell death was inhibited in these animals.
To test further the hypothesis that overexpression ofgenomic sequences with the C. elegans genomic se-
quence, we found that exons were in general more con- ced-4L inhibited programmed cell death, we introduced
a transgene containing a ced-4L cDNA fused to theserved among these genes than were introns, with the
exception of intron 3 (Figure 1A). The 72 bp at the 39 constitutive promoter of the dpy-30 gene (D. Hsu and
B. Meyer, personal communication) into animals con-end of intron 3 (as defined by previously described C.
elegans ced-4 cDNAs; Yuan and Horvitz, 1992) were taining a ced-9(lf) mutation. ced-9(lf) homozygous ani-
mals derived from ced-9(lf)/1 heterozygous mothershighly conserved (Figure 1B), suggesting that this region
is important for ced-4 function. In all three species, this generate progeny that die from massive ectopic cell
death and can be rescued by mutations that prevent72 bp region was immediately preceded by a consensus
splice-acceptor sequence (TTNNAG; T, A, and G are programmed cell death (Hengartner et al., 1992). ced-
9(lf) mutants carrying the Pdpy-30ced-4L transgene werepresent in >90% of sites, while N represents a more
variable position; Emmons, 1988) (Figure 1B), sug- rescued from lethality (Table 2), supporting the notion
that ced-4L can prevent programmed cell death.gesting that this region might be used as an exon.
To determine whether C. elegans ced-4 encodes an
alternative transcript that uses this presumptive splice- ced-4 Encodes Protective as Well as Killer
acceptor site, we hybridized a radioactive probe corre- Genetic Functions
spondingto the 72bp conservedsequence to a Northern The observation that ced-4 encodes a death-preventing
blot of mixed-stage C. elegans poly(A)1 RNA prepared as well as a death-promoting transcript suggests that
from wild-type animals. As shown in Figure 1C, a 2.2 kb ced-4 might function in vivo not only to cause but also
transcript was seen. This transcript is 10- to 30-fold less to protect against programmed cell death. Evidence
abundant than the previously described ced-4 transcript consistent with such a protective in vivo function of
(data not shown) and is similar to it in size (Yuan and ced-4 was obtained some years ago by Ellis and Horvitz
Horvitz, 1992). To determine whether this ced-4 tran- (1986), although there was no basis for interpreting their
script was produced by splicing at an acceptor site at data at that time. Specifically, the egl-1(n487) mutation
position 114 of intron 3 (see Figure 1B), we prepared causes the HSN neurons to undergo programmed cell
cDNAs from the same RNA preparation used for the death, and the percentage of dying HSNs is lower
Northern blot. These cDNAs were used with primers in egl-1(n487)/1 heterozygous animals than in ced-
flanking intron 3 to amplify the region encompassing 4(n1162)/1; egl-1(n487)/1 doubly heterozygous ani-
this intron by the polymerase chain reaction (PCR). We mals. Since the n1162 mutation eliminates ced-4 func-
observed two products (Figure 1D). Sequence analysis tion (Ellis and Horvitz, 1986; Yuan and Horvitz, 1992;
of these products confirmed that the longer one (called S. S. and H. R. H., unpublished data), this observation
ced-4L, for ced-4 long) corresponded to a ced-4 RNA indicates that a reduction of ced-4 activity can lead to
spliced at position 114 of intron 3 and the shorter one an increase in programmed cell death, i.e., that ced-4
(called ced-4S, for ced-4 short) corresponded to the can protect against programmed cell death.
previously described ced-4 mRNA (data not shown).
These results indicate that ced-4 generates two alterna-
The ced-4 Allele n2273 Perturbs Both Killertively spliced transcripts (Figures 1B and 1E). The ced-
and Protective ced-4 Functions4L transcript contains an in-frame insertion of 72 nt
To confirm further that ced-4 encodes a death-pre-relative to the previously described ced-4S transcript
venting function and to examine whether this functionand could encode a protein with a 24 amino acid inser-
and the death-promoting function of ced-4 might betion relative to CED-4S (see Figure 1B).
encoded by the ced-4L and ced-4S transcripts, respec-
tively, we characterized the effects of the ced-4(n2273)Overexpression of ced-4L Can Prevent
mutation, which changes a conserved G to an A at theProgrammed Cell Death
ced-4S-specific splice-acceptor site of intron 3 (YuanWe previously demonstrated that the ALM neurons,
and Horvitz, 1992; see Figure 1B) and thus might bewhich normally express the mec-7 gene (Savage et al.,
useful for distinguishing the functions of the two ced-41989), undergo programmed cell death in animals car-
transcripts. We examined ced-4 transcripts in ced-rying a transgene consisting of the ced-4S cDNA fused
4(n2273) mutants by probing a Northern blot of poly(A)1to the mec-7 promoter (Pmec-7 ced-4S) (Shaham and Hor-
RNA from ced-4(n2273) animals with either a probe con-vitz, 1996). This result suggested that ced-4S nor-
sisting of the 72 bp conserved region of intron 3 (de-mally promotes programmed cell death. To determine
tecting only the ced-4L transcript) or a full-length ced-whether ced-4L also promotes programmed cell death,
4S cDNA probe (detecting both the ced-4S and ced-4Lwe established transgenic lines containing a ced-4L
transcripts). As shown in Figure 1C, expression of ced-cDNA fused to Pmec-7. No ectopic cell deaths were ob-
served (data not shown). We also established transgenic 4L in ced-4(n2273) animals was enhanced compared
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Figure 1. ced-4 Encodes Two Alternatively
Spliced Transcripts
(A) Diagram showing the conservation of
ced-4 genomic nucleotide sequences among
C. elegans, C. briggsae, and C. vulgaris.
Boxes represent exons, horizontal lines rep-
resent introns, broken lines indicate align-
ments, numbers above and below the C. ele-
gans diagram indicate the percent nucleotide
identity between C. elegans and C. vulgaris
and C. elegans and C. briggsae, respectively.
Only a partial C. vulgaris clone was isolated.
(B) Alignment of the 77 bp sequence at the
39 end of intron 3 from C. elegans, C. brigg-
sae, and C. vulgaris. Numbers at the ends of
the C. elegans sequence indicate positions
within intron 3. Residues conserved among
all species are boxed.The putative C. elegans
protein sequence encoded by this region is
indicated below the alignment. Consensus
splice-acceptor sites (Emmons, 1988) (TTN
NAG) are indicated by horizontal bars. Arrows
indicate positions of splicing in ced-4L and
ced-4S transcripts. Nucleotide and corre-
sponding amino acid changes in ced-
4(n2273) animals are indicated.
(C) Left: Northern blot of wild-type and ced-
4(n2273) poly(A)1 RNA probed with a 72 bp
fragment corresponding to the ced-4L-spe-
cific sequence (2.2 kb) or with a probe for the
gene that encodes the C. elegans L5 ribo-
somal protein (M. Koelle, personal communi-
cation) (0.9 kb) as a loading control. Right:
equivalent blot of wild-type and ced-4(n2273)
poly(A)1 RNA probed with a full-length ced-
4S probe (2.2 kb) or with a probe for the gene
that encodes the C. elegans L5 ribosomal
protein as a loading control (0.9 kb).
(D) Agarose gel stained with ethidium bro-
mide showing products generated by PCR
using primers flanking intron 3 from wild-type
and ced-4(n2273) RNA (see Experimental
Procedures for details). Numbers show 123
bp ladder marker sizes.
(E) Drawing showing splicing patterns that
generate the ced-4S and ced-4L transcripts.
Open boxes represent exons, and V-shaped
lines represent introns. AUG start and UAA
stop codons are indicated. Numbers indicate
nucleotide positions within an unspliced
ced-4 mRNA beginning at the AUG and end-
ing at the poly(A) addition site (Yuan and Hor-
vitz, 1992).
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Table 3. ced-4(n2273) Can Enhance Killing by Programmed CellTable 1. Overexpression of ced-4L Can Prevent Programmed
Cell Death Death
Transgene Heat Shock Number of Extra Cells (n) Range Percent Viable
Genotype Progeny (n)
hsp–ced-4L-1 1 7.0 6 0.9 (21) 0–13
hsp–ced-4L-1 2 0.07 6 0.07 (15) 0–1 ced-4(n2273) 98 (707)
ced-9(n1653) 99.6 (926)hsp–ced-4L-2 1 10 6 0.6 (15) 5–14
hsp–ced-4L-2 2 0.2 6 0.1 (15) 0–1 ced-4(n2273) ced-9(n1653) 0.3 (532)
ced-4(n2273) ced-9(n1653); ced-3(n2427) 98 (651)hsp–ced-4L-3 1 7.7 6 0.7 (15) 4–12
hsp–ced-4L-3 2 0.07 6 0.07 (15) 0–1 ced-4(n2273) ced-9(n1653); ced-3(n2438) 97 (583)
Heat-shock constructs were made by cloning a ced-4 cDNA into We allowed 10–20 animals of each genotype to lay eggs for 3–5
days. Animals progressing past the L3 stage were scored as viable.the heat-shock promoter vectors pPD49.79 and pPD49.83 (A. Fire,
personal communication) and injected into wild-type animals. n, number of eggs laid. Experiments were done at 208C.
Transgenic adults were allowed to lay eggs for 2 hr at 208C, sub-
jected to a 60 min heat shock at 338C, allowed to lay eggs for an
additional 2 hr, and removed from the petri plate. Hatched L4 roller observed in these animals both byus and by M. Hengart-
larvae were scored for extra cells in the anterior pharynx as pre- ner and H. R. H. (unpublished data). Specifically, the
viously described (Hengartner et al., 1992). Number of extra cells, anterior pharynx of ced-4(n2273) animals contained on
average number of extra cells 6 standard error of the mean. n,
average 2.9 extra cells that failed to undergo pro-number of animals observed. Range, range of extra cells seen in
grammed cell death (see Table 4). Since ced-4(n2273)individual animals.
animals produced a mutated ced-4L product, we sur-
mised that they also might have a defect in a death-
preventing function of ced-4. To test this hypothesis,
we examined the effect of introducing the weak loss-with expression in wild-type animals, suggesting that in
ced-4(n2273) animals the ced-4L-specific splice-accep- of-function ced-9 allele n1653 (Hengartner et al., 1992)
into ced-4(n2273) animals. Although both ced-9(n1653)tor site might be used more often than in wild-type an-
imals. animals and ced-4(n2273) animals produce mostly via-
ble progeny, doubly mutant ced-4(n2273) ced-9(n1653)To determine the splicing pattern of ced-4 transcripts
in ced-4(n2273) animals, we amplified by PCR the ced- animals derived from ced-4(n2273) ced-9(n1653)/11
parents produced mostly dead progeny (Table 3; M.4S and ced-4L transcripts using primers flanking the
ced-4L-specific exon. Separation of the amplified prod- Hengartner, personal communication), and this effect
was blocked by preventing programmed cell death withucts on an agarose gel yielded two bands (Figure 1D).
Sequence determination revealed that the larger prod- a mutation in ced-3. This result suggests that ced-
4(n2273) enhanced programmed cell death caused byuct corresponded to the wild-type ced-4L transcript,
except for a G-to-Achange at the ced-4(n2273) mutation the ced-9(n1653) allele. This enhancement of cell death
is opposite to the reduction of cell death in ced-4(n2273)site (see Figure 1B), presumably causing an arginine-
to-lysine substitution in the CED-4L protein. The smaller single mutant animals and suggests that ced-4(n2273)
is defective in a death-preventing as well as a death-band contained two distinct products. One product cor-
responded to the wild-type ced-4S transcript except for promoting function.
To test this hypothesis further, we showed that ced-a 3 bp deletion immediately downstream of the ced-
4S-specific splice-acceptor site. This transcript would 4(n2273)/ced-4(1) animals did not contain extra surviv-
ing cells in the anterior pharynx and that ced-4(n2273)/presumably result in the deletion of Ser-211 of CED-4S.
The second product corresponded to a ced-4S tran- ced-4(null) animals had more surviving cells than ced-
4(n2273)/ced-4(n2273) mutants (data not shown), whichscript spliced at position 185 instead of 186 of the se-
quence shown in Figure 1B, resulting in an insertion supports the hypothesis that ced-4(n2273) results in a
reduction of ced-4S activity. Overexpression of a ced-of an A nucleotide relative to the wild-type sequence.
Translation of this frameshifted product would presum- 4L cDNA harboring the n2273 mutation reduced (but did
not eliminate) extra cell survival compared with overex-ably terminate prematurely at a TGA stop codon 85 bp
downstream of the insertion site. pression of ced-4L(1) (Table 1;data not shown). Further-
more, in a ced-9(n1653) background, ced-4(n2273)/ced-That ced-4S transcripts are abnormal in ced-4(n2273)
mutants is consistent with a weak defect in cell killing 4(1) animals were alive, whereas both ced-4(n2273)/
Table 2. Overexpression of ced-4L Can Rescue ced-9(lf) Animals from Lethality
Number of Progeny per 20 Animals
Transgene ced-9(n1950n2161) ced-9(n1950n2077) ced-9(n2812)
Pdpy-30ced-4L 192 6 24 67 6 30 11 6 3
Pdpy-30ced-4L(frameshift) 0 0 ND
None 0 0 0
Constructs were injected into unc-69(e587) ced-9(n1950n2161)/qC1, unc-69(e587) ced-9(n1950n2077)/qC1, and ced-9(n2812)/qC1 animals,
and progeny of Ced-9 animals were examined. We allowed 20 animals of each genotype and containing a given transgene to produce progeny.
The number of live progeny produced is shown. For the transgenic animals, this number represents the average number 6 standard deviation
of progeny produced by three independent lines. ND, not determined.
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slightly fewer, rather than more, extra cells when com-Table 4. ced-4L Might Be Negatively Regulated by ced-9
pared with ced-4(n2273); ced-3(n2427 or n2438) dou-
Number of
ble mutants, respectively (Table 4). For example, ced-Genotype Extra Cells (n)
4(n2273) ced-9(n1653); ced-3(n2427) animals contained
Wild type 0.1 6 0.4 (40) on average 8.7 6 0.4 extra cells in the anterior pharynx,
ced-9(n1653) 0.3 6 0.5 (15)
whereas ced-4(n2273); ced-3(n2427) animals containedced-4(n2273) 2.9 6 0.4 (15)
10.1 6 0.3 extra cells. These results suggest that ced-
ced-9 enhances cell survival in ced-3 (weak) mutants 4(n2273) (which is defective in ced-4L function) pre-
ced-3(n2427) 1.2 6 0.2 (19) vented the ability of ced-9(n1653) to enhance cell sur-
ced-3(n2438) 2.1 6 0.4 (10) vival and indicate that ced-9 can cause cell death by
ced-9(n1653); ced-3(n2427) 7.4 6 0.5 (15)* inhibiting the activity of ced-4L. That animals carrying
ced-9(n1653); ced-3(n2438) 8.2 6 0.4 (15)*
the ced-3(n2433), ced-4(n1162), and ced-9(n1950) mu-
ced-4(n2273) prevents ced-9 enhancement of cell survival tations contain on average 12.4, 12.2, and 12.5 (Table
ced-4(n2273); ced-3(n2427) 10.1 6 0.3 (15) 4) extra cells, respectively, in the anterior pharynx sug-
ced-4(n2273); ced-3(n2438) 11.9 6 0.3 (15) gests that if ced-9(n1653) could enhance cell survival
ced-4(n2273) ced-9(n1653); ced-3(n2427) 8.7 6 0.4 (15)** in ced-4(n2273); ced-3(weak) animals, we would have
ced-4(n2273) ced-9(n1653); ced-3(n2438) 10.9 6 0.3 (15)***
been able to detect this enhancement.
ced-4(n2273) reduces cell survival caused by ced-9(n1950)
ced-9(n1950) 12.5 6 0.2 (15)
ced-4(n2273) ced-9(n1950) 10.1 6 0.4 (14)* n1950, a Death-Preventing ced-9 Allele,
Might Be Unable to Inhibit ced-4LIn the top section are our reference data for wild-type, ced-9(n1653),
The ced-9(n1950) allele dominantly inhibits programmedand ced-4(n2273) animals. Extra cells were scored as in Table 1.
Number of extra cells, average number of extra cells 6 standard cell death (Hengartner and Horvitz, 1994a) and changes
error of the mean. n, number of animals observed. Single asterisk, a conserved glycine to a glutamic acid in the BH1 do-
unpaired Student’s t test p , 0.001; double asterisk, p , 0.01; triple main of the CED-9 protein. The equivalent domain in
asterisk, p , 0.04. See text for relevant comparisons.
BCL-2 mediates BCL-2–BAX interaction and is required
for BCL-2 to prevent cell death (Yin et al., 1994). ced-
9(n1950) was proposed to activate the CED-9 proteinced-4(n2273) and ced-4(n2273)/ced-4(null) animals
(Hengartner and Horvitz, 1994a); however, a similarwere dead. These results support the hypothesis that
change in BCL-2 surprisingly resulted in loss of activityced-4(n2273) also results in a reduction but not a total
in both mammalian cells and in C. elegans (Yin et al.,loss of ced-4L activity.
1994; Hengartner and Horvitz, 1994a). We observed that
ced-4(n2273) ced-9(n1950) double mutants containedced-9 Inhibits Both Protective and Killer
fewer extra cells than didced-9(n1950) animals (Table 4).ced-4 Activities
That ced-4(n2273), which isdefective in ced-4L function,Previous studieshave indicated that the cell-killing func-
reduces the extent of cell survival caused by ced-tion of ced-4, which we now attribute to ced-4S, is inhib-
9(n1950) suggests that ced-9(n1950) causes cellsurvivalited by ced-9 (Hengartner et al., 1992; Shaham and Hor-
at least in part as a result of an increase in ced-4Lvitz, 1996). How does ced-4L interact with ced-9 and
activity. We propose, therefore, that ced-9(n1950) canced-4S? First, as described above, overexpression of
inhibit ced-4S, but not ced-4L. If so, the ced-9(n1950)ced-4Lcan rescue the lethalitycaused by a loss of ced-9
phenotype would bea consequence not of the activationfunction, suggesting that ced-4L functions downstream
of CED-9, but rather of the loss of the inhibitory actionof or in parallel to ced-9. Second, ced-9 can inhibit the
of CED-9 on CED-4L. Consistent with this observation,killing of ALM neurons caused by ced-4S overexpres-
Hengartner et al. (1992) showed that ced-9 product ission in animals homozygous for the ced-4(n1162) allele
maternally contributed to the embryo. If ced-9(n1950)and thus lacking all ced-4L function (Shaham and Hor-
resulted in increased ced-9 protective activity, genotypi-vitz, 1996), suggesting that ced-9 does not require ced-
cally wild-type self-progeny of ced-9(n1950)/1 parents4L function to inhibit ced-4S function. Third, ced-9 ap-
might well have extra surviving cells. However, suchpears to inhibit not only the activity of ced-4S, but also
progeny do not have extra surviving cells (Hengartnerthe activity of ced-4L. Specifically, Hengartner and Hor-
et al., 1992), as would be expected if the n1950 allelevitz (1994a) reported that ced-9 has not only a death-
instead lacked a killing activity.preventing but also a death-promoting function: muta-
tions that decrease ced-9 activity lead to enhanced
rather than diminished cell survival in mutants slightly
Discussionreduced in ced-3 function. For example, as we show in
Table 4, ced-9(n1653); ced-3(n2427) animals contained
Our results suggest that ced-4 encodes two opposingan average of 7.4 6 0.5 extra cells in the anterior phar-
cell death functions mediated by two alternatively tran-ynx, whereas ced-3(n2427) animals contained only 1.2 6
scribed ced-4 mRNAs, ced-4L and ced-4S. Our experi-0.2 extra cells. Does this death-promoting ced-9 func-
ments indicate that alternative splicing is normally usedtion require ced-4L activity? To answer this question, we
in vivo to regulate programmed cell death. Two mamma-determined whether the ced-4(n2273) mutation, which
lian genes have been shown to encode alternativelypresumably reduces ced-4L function, affects this death-
spliced products that have opposing cell death func-promoting activity. We found that ced-4(n2273) ced-
9(n1653); ced-3(n2427 or n2438) triple mutants had tions when overexpressed, although in neither case
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ced-9 preferentially inhibits ced-4S in cells that normally
live and preferentially inhibits ced-4L in cells that nor-
mally die. Differential inhibition of ced-4S or ced-4L in
different cells by ced-9 could reflect differences in the
splicing pattern of ced-4 between cells that normally
die and those that normally live. Specifically, ced-4S
could be produced at lower levels compared with ced-
4L in cells that normally live and at higher levels com-
pared with ced-4L in cells that normally die.
The models presented in Figure 2 offer a possible
explanation for the effect of the ced-9(n1950) mutant,
which causes a Gly-169 to glutamate substitution and
results in extra cell survival (Hengartner and Horvitz,
Figure 2. Alternative Models for the Regulation of Programmed Cell 1994a): rather than activating the CED-9 protein as origi-
Death in C. elegans
nally suggested, this mutation might specifically inacti-
The ced-9 gene product can inhibit the functions of both the ced-
vate the ability of the CED-9 protein to inhibit CED-4S and the ced-4L products. ced-4S promotes programmed cell
4L, thereby allowing CED-4L to prevent cell death anddeath, and ced-4L prevents programmed cell death. ced-9 can pre-
vent cell death by inhibiting ced-4S and can promote cell death by causing increased cell survival. A glycine to glutamate
inhibiting ced-4L. ced-4L inhibits cell death either by inhibiting ced- mutation at the identical site of the BH1 domain of the
4S activity (above) or by interfering with a consequence of ced- BCL-2 protein inactivates BCL-2, apparently because
4S action (below). Pointed and blunt arrows indicate positive and
the protein loses the ability to form heterodimers withnegative regulation, respectively.
other BCL-2 family members (Yin et al., 1994). We pro-
pose that the n1950 mutation similarly results in loss
of a protein–protein interaction, i.e., of an interaction
have opposing normal in vivo activities been demon- between CED-9 and CED-4L or between CED-9 and a
strated. bcl-x, a bcl-2-like gene, encodestwo transcripts protein that mediates CED-4L activity. In the case of
(Boise et al., 1993). As in the case of ced-4, the longer BCL-2, this loss of interaction results in inability to pro-
bcl-x transcript, bcl-xL, can protect cells from cell death, tect against cell death, whereas in the case of CED-9
and the shorter transcript, bcl-xS, can accelerate cell this loss of interaction results in inability to cause cell
death. Ich-1, a ced-3/Ice-like protease, also encodes death. Alternatively, CED-9 might regulate other aspects
two transcripts (Wang et al., 1994). Ich-1L encodes a of ced-4 function such as alternative splicing, transcrip-
full-length protease that can cause apoptosis, whereas
tion, or biochemical activity. Since mutations that give
the truncated Ich-1S product presumably encodes an rise to excess cell survival may result in malignant
inactive protease that can prevent apoptosis. Of these
growth (Vaux et al., 1988), it is possible that dominant
four transcripts, only bcl-xL has been shown normally oncogenes exist that encode BCL-2 family members
to play a role in vivo. The observation that three classes
that cannot inhibit a CED-4L functional counterpart.
of cell death genes apparently unrelated by primary se-
Such a mechanism for oncogenesis would contrast with
quence (ced-4, bcl-x, and Ich-1) are all alternatively
the dominant induction of cancerous growth caused by
spliced suggests that factors involved in RNA splicing
overexpression of a BCL-2-like protective protein, asmay regulate programmed cell death by the coordinate
seen in follicular lymphomas (Yunis et al., 1987).differential splicing of a number of cell death–related
Another feature of the models presented in Figure 2primary transcripts.
is that they suggest that ced-9 can act either to preventTwo alternative models for the genetic pathway for
or to promote cell death depending on its relative effectsprogrammed cell death in C. elegans (Figure 2) are con-
on ced-4S and ced-4L. Thus, a single cell-death proteinsistent with our observations that ced-4L acts down-
can mediate both survival and killing. Two mammalianstream of or in parallel to ced-9, that ced-9 can inhibit
bcl-2 family members, Bax and Bak, as well as bcl-2ced-4S-induced killing in the absence of ced-4L (Sha-
itself might be bifunctional in this way. A mutation in theham and Horvitz, 1996), and that ced-9 can inhibit both
mouse Bax gene was found recently to result in eitherced-4L and ced-4S. In both models, ced-9 negatively
hypoplasia or hyperplasia, depending on the tissue ex-regulates ced-4L and ced-4S, and the antagonistic ac-
amined (Knudson et al., 1995). This result suggests thattivities of ced-4L and ced-4S compete to determine
Bax might be able either to promote or to prevent cellwhether a cell lives or dies. Since ced-4 null mutants,
death. Similarly, Bak accelerates cell death in a numberwhich lack both ced-4L and ced-4S transcripts, are via-
of cell lines (Chittenden et al., 1995; Farrow et al., 1995;ble animals containing many extra cells (Ellis and Hor-
Kiefer et al., 1995) and prevents cell death in othersvitz, 1986; Yuan and Horvitz, 1992; S. S. and H. R. H.,
(Kiefer et al., 1995). Finally, bcl-2 can both potentiateunpublished data), ced-4S may well function down-
and prevent cell death in response to different cell deathstream of ced-4L. However, our results do not reveal
stimuli (Cortazzo and Schor, 1996). We suggest thatwhether ced-4L inhibits programmed cell death by pre-
bcl-2, Bax, Bak, and other mammalian bcl-2/ced-9 fam-venting ced-4S activity directly or by interfering with
ily members can both promote and prevent programmeda consequence of ced-4S action, as indicated by the
cell death by interacting with mammalian functionalalternative models shown in Figure 2.
counterparts of CED-4S and CED-4L, which might differHow might ced-4L, ced-4S, and ced-9 interact to reg-
ulate programmed cell death? One possibility is that in distribution among distinct cell and tissue types.
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Experimental Procedures from each of 20 colonies resulting from each ligation was purified,
and insert sequences were determined using an ABI 373A se-
quencer.General Methods and Strains
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